Cited by 169Stress Responses and CortisolTryptophan and brain disordersNeuropeptides and Animal Physiology

The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.

HPA and Immune Axes in Stress: Involvement of the Serotonergic System

Leonard, Brian E.·2006·Neuroimmunomodulation

Open this paper in CoChat — free account

Abstract

Chronic stress, by initiating changes in the hypothalamic-pituitary-adrenal axis and the immune system, acts as a trigger for anxiety and depression. There is experimental and clinical evidence that the rise in the concentration of pro-inflammatory cytokines and glucocorticoids, which occurs in a chronically stressful situation and also in depression, contributes to the behavioural changes associated with depression. A defect in serotonergic function is associated with these hormonal and immune changes. Neurodegenerative changes in the hippocampus, prefrontal cortex and amygdalae are the frequent outcomes of the changes in the hypothalamic-pituitary-adrenal axis and the immune system. Such changes may provide evidence for the link between chronic depression and dementia in later life.

Integrity signals

Registry

Crossref · 10.1159/000104854

Cites

69 of 69 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region
Lesch, K.-P., Bengel, D., Heils, A., Sabol, S. Z., Greenberg, B. D., Petri, S., Benjamin, J., Müller, C. R., Hamer, D. H., & Murphy, D. L. (1996) · Science · doi:10.1126/science.274.5292.1527 · Cited by 5,162
A Syndrome produced by Diverse Nocuous Agents
Selye, H. (1936) · Nature · doi:10.1038/138032a0 · Cited by 3,967
The Concepts of Stress and Stress System Disorders: Overview of Physical and Behavioral Homeostasis
Chrousos, G. P. (1992) · JAMA · doi:10.1001/jama.1992.03480090092034 · Cited by 2,689
A molecular and cellular theory of depression
Duman, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830190015002 · Cited by 2,129
Glial reduction in the subgenual prefrontal cortex in mood disorders
Öngür, D., Drevets, W. C., & Price, J. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13290 · Cited by 1,525
Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression∗∗See accompanying Editorial, in this issue.
Rajkowska, G., Miguel-Hidalgo, J. J., Wei, J., Dilley, G., Pittman, S. D., Meltzer, H. Y., Overholser, J. C., Roth, B. L., & Stockmeier, C. A. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00041-4 · Cited by 1,477
Depression Duration But Not Age Predicts Hippocampal Volume Loss in Medically Healthy Women with Recurrent Major Depression
Sheline, Y. I., Sanghavi, M., Mintun, M. A., & Gado, M. H. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-12-05034.1999 · Cited by 1,382 · cited 1×
“The microglia are known to produce both 3-hydroxyanthranilic acid and quinolinic acid in depression, while the astrocytes produce mainly kynurenic acid. Astrocytes also metabolise quinolinic acid and thereby reduce the neurotoxic impact of microglia activation [”
Background
The role of corticotropin-releasing factor in depression and anxiety disorders
Arborelius, L., Owens, M., Plotsky, P., & Nemeroff, C. (1999) · Journal of Endocrinology · doi:10.1677/joe.0.1600001 · Cited by 1,378
Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression
Chalmers, D., Lovenberg, T. W., & Souza, E. D. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-10-06340.1995 · Cited by 925
A review of psychoendocrine research on the pituitary–adrenal cortical system
MASON, J. W. (1968) · Psychosomatic Medicine · doi:10.1097/00006842-196809000-00020 · Cited by 874
An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid
Perkins, M. N., & Stone, T. W. (1982) · Brain Research · doi:10.1016/0006-8993(82)91048-4 · Cited by 849
Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain.
Lovenberg, T. W., Liaw, C. W., Grigoriadis, D. E., Clevenger, W., Chalmers, D. T., Souza, E. B. D., & Oltersdorf, T. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.3.836 · Cited by 846
Endogenous kynurenines as targets for drug discovery and development
Stone, T. W., & Darlington, L. G. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd870 · Cited by 768
Stressors, Stress, and Neuroendocrine Integration of the Adaptive Response: The 1997 Hans Selye Memorial Lecture
Chrousos, G. P. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb09006.x · Cited by 731
Tryptophan depletion causes a rapid lowering of mood in normal males
Young, S. N., Smith, S. E., Pihl, R. O., & Ervin, F. R. (1985) · Psychopharmacology · doi:10.1007/bf00431803 · Cited by 715
Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer’s disease brain contribute to neuronal death1
Allanbutterfield, D., Castegna, A., Lauderback, C. M., & Drake, J. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00340-2 · Cited by 715
The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety
Holsboer, F. (1999) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(98)90056-5 · Cited by 654
Depression as a Risk Factor for Alzheimer Disease: The MIRAGE Study
Green, R. C., Cupples, L. A., Kurz, A., Auerbach, S., Go, R., Sadovnick, D., Duara, R., Kukull, W. A., Chui, H., Edeki, T., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.5.753 · Cited by 551
Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection
Guillemin, G. J., Kerr, S. J., Smythe, G. A., Smith, D. G., Kapoor, V., Armati, P. J., Croitoru‐Lamoury, J., & Brew, B. J. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00498.x · Cited by 541
Polymorphism in serotonin transporter gene associated with susceptibility to major depression
Ogilvie, A. D., Battersby, S., Fink, G., Harmar, A. J., Goodwin, G. M., Bubb, V. J., & Smith, C. A. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90079-3 · Cited by 534
Kynurenine pathway in major depression: Evidence of impaired neuroprotection
Myint, A.-M., Kim, Y. K., Verkerk, R., Scharpé, S., Steinbusch, H., & Leonard, B. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.07.013 · Cited by 527
Self-citation
Depression, stress and immunological activation: The role of cytokines in depressive disorders
Connor, T. J., & Leonard, B. E. (1998) · Life Sciences · doi:10.1016/s0024-3205(97)00990-9 · Cited by 480
Self-citation
A re-evaluation of the concept of ‘non-specificity’ in stress theory
Mason, J. W. (1971) · Journal of Psychiatric Research · doi:10.1016/0022-3956(71)90028-8 · Cited by 479
IDO and interferon-α-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity
Wichers, M. C., Koek, G. H., Robaeys, G., Verkerk, R., Scharpé, S., & Maes, M. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001600 · Cited by 445
Cytokine–serotonin interaction through IDO: a neurodegeneration hypothesis of depression
Myint, A.-M., & Kim, Y. K. (2003) · Medical Hypotheses · doi:10.1016/s0306-9877(03)00207-x · Cited by 387
Cortisol Production in Depressive Illness
Sachar, E. J. (1970) · Archives of General Psychiatry · doi:10.1001/archpsyc.1970.01750040001001 · Cited by 371
Th1, Th2, and Th3 cytokine alterations in major depression
MYINT, A., LEONARD, B., STEINBUSCH, H., & KIM, Y. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.07.008 · Cited by 371
Self-citation
The temporal relationship between depressive symptoms and dementia—A community-based prospective study
Chen, P., Ganguli, M., Mulsant, B. H., & DeKosky, S. T. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.3.261 · Cited by 327
Corticotropin-releasing factor and neuropeptide y: role in emotional integration
Heilig, M. A., Koob, G. F., Ekman, R., & Britton, K. T. (1994) · Trends in Neurosciences · doi:10.1016/0166-2236(94)90079-5 · Cited by 324
Amygdaloid CRF Pathways: Role in Autonomic, Neuroendocrine, and Behavioral Responses to Stress
Gray, T. S. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb49922.x · Cited by 288
Serotonin receptor binding in a colony model of chronic social stress
McKittrick, C. R., Blanchard, D. C., Blanchard, R. J., McEwen, B. S., & Sakai, R. R. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(94)00152-s · Cited by 281
Role of the Serotonin Transporter Promoter Polymorphism in Anxiety-Related Traits
Mazzanti, C. M., Lappalainen, J., Long, J. C., Bengel, D., Naukkarinen, H., Eggert, M., Virkkunen, M. E., Linnoila, M., & Goldman, D. A. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.10.936 · Cited by 251
Repeated stress increases catalytic TrkB mRNA in rat hippocampus
Nibuya, M., Takahashi, M., Russell, D., & Duman, R. S. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00335-3 · Cited by 236
Serotonin 5-HT2a and 5-HT2c Receptors Stimulate Amyloid Precursor Protein Ectodomain Secretion
Nitsch, R. M., Deng, M., Growdon, J. H., & Wurtman, R. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.8.4188 · Cited by 219
Neuropsychological Differences Between Late-Onset and Recurrent Geriatric Major Depression
Rapp, M. A., Dahlman, K., Sano, M., Grossman, H. T., Haroutunian, V., & Gorman, J. M. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.4.691 · Cited by 219
Corticosterone and Serotonergic Neurotransmission in the Hippocampus: Functional Implications of Central Corticosteroid Receptor Diversity
Meijer, O. C., & de Kloet, E. R. (1998) · Critical Reviews in Neurobiology · doi:10.1615/critrevneurobiol.v12.i1-2.10 · Cited by 203
Prolactin and cortisol responses to d-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function
O’Keane, V., & Dinan, T. G. (1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.8.1009 · Cited by 203
Changes in immunoglobulin, complement and acute phase protein levels in the depressed patients and normal controls
Song, C., Dinan, T. G., & Leonard, B. E. (1994) · Journal of Affective Disorders · doi:10.1016/0165-0327(94)90135-x · Cited by 193
Self-citation
Leukocytosis, monocytosis and neutrophilia: Hallmarks of severe depression
Maes, M., Van Der Planken, M., Stevens, W. J., Peeters, D., DeClerck, L. S., Bridts, C. H., Schotte, C., & Cosyns, P. (1992) · Journal of Psychiatric Research · doi:10.1016/0022-3956(92)90004-8 · Cited by 186
Stress — mechanisms of immunosuppression
Dohms, J. E., & Metz, A. L. (1991) · Veterinary Immunology and Immunopathology · doi:10.1016/0165-2427(91)90011-z · Cited by 181
A mechanism of quinolinic acid formation by brain in inflammatory neurological disease: Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate
Heyes, M. P., Saito, K., Major, E. O., Milstien, S., Markey, S. P., & Vickers, J. H. (1993) · Brain · doi:10.1093/brain/116.6.1425 · Cited by 171
Biologic-response-modifier-induced indoleamine 2,3-dioxygenase activity in human peripheral blood mononuclear cell cultures.
Carlin, J. M., Borden, E. C., Sondel, P., & Byrne, G. I. (1987) · Journal of Immunology · doi:10.4049/jimmunol.139.7.2414 · Cited by 160
Interleukin-4 inhibits indoleamine 2,3-dioxygenase expression in human monocytes.
Musso, T., Gusella, G., Brooks, A., Longo, D., & Varesio, L. (1994) · Blood · doi:10.1182/blood.v83.5.1408.1408 · Cited by 158
Quinolinate neurotoxicity in cortical cell culture
Kim, J. P., & Choi, D. W. (1987) · Neuroscience · doi:10.1016/0306-4522(87)90066-2 · Cited by 144
Decreased serum and red blood cell kynurenic acid levels in Alzheimer's disease
Hartai, Z., Juhász, A., Rimanóczy, Á., Janáky, T., Donkó, T., László, A., Penke, B., Tóth, G. K., Janka, Z., & Kalman, J. L. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2006.08.012 · Cited by 139
Hippocampal Volume and Incident Dementia in Geriatric Depression
Steffens, D. C., Payne, M. E., Greenberg, D. L., Byrum, C. E., Welsh-Bohmer, K. A., Wagner, H. R., & MacFall, J. R. (2002) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200201000-00008 · Cited by 128
Synthesis and release of neurotoxic kynurenine metabolites by human monocyte-derived macrophages
Chiarugi, A., Calvani, M., Meli, E., Traggiai, E., & Moroni, F. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00418-0 · Cited by 125
Age and the dexamethasone suppression test in depression
Davis, K. L., Davis, B. J., Mathé, A. A., Mohs, R. C., Rothpearl, A., Levy, M. I., Gorman, L. K., & Berger, P. A. (1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.7.872 · Cited by 119
Regulation of 5‐HT receptors by corticosteroids: where do we stand?
Chaouloff, F. (1995) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.1995.tb00289.x · Cited by 112
Stress and the Individual: Mechanisms Leading to Disease
McEwen, B. S. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.1993.00410180039004 · Cited by 103
Murine Glial Cells Regenerate NAD, After Peroxide‐Induced Depletion, Using Either Nicotinic Acid, Nicotinamide, or Quinolinic Acid as Substrates
Grant, R., & Kapoor, V. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70041759.x · Cited by 91
Faulty cortisol/serotonin interplay. Psychopathological and biological characterisation of a new, hypothetical depression subtype (SeCA depression)
van Praag, H. M. (1996) · Psychiatry Research · doi:10.1016/s0165-1781(96)02923-x · Cited by 87
Inflammation and depression: Is there a causal connection with dementia?
E.Leonard, B., & Myint, A. (2006) · Neurotoxicity Research · doi:10.1007/bf03033243 · Cited by 76
Use of the dexamethasone suppression test in depression.
Carroll, B. J. (1982) · PubMed · Cited by 70
Modulation of the immune response by emotional stress
Croiset, G., Heijnen, C. J., Veldhuis, H. D., de Wied, D., & BALLIEUX, R. E. (1987) · Life Sciences · doi:10.1016/0024-3205(87)90305-5 · Cited by 66
Serotonin transporter binding sites and mRNA levels in depressed persons committing suicide
Little, K. Y., McLauglin, D. P., Ranc, J., Gilmore, J. H., López, J. F., Watson, S. J., Carroll, F. I., & Butts, J. D. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00301-0 · Cited by 64
Effects of 5-HT1A receptor agonists on hypothalamo-pituttary-adrenal axis activity and cortlcotropin-releasing factor containing neurons in the rat brain
Owens, M. J., Edwards, E., & Nemeroff, C. B. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)94118-h · Cited by 64
Effect of selective serotonin agonists on basal, corticotrophin-releasing hormone- and vasopressin-induced ACTH release in vitro from rat pituitary cells
Calogero, A. E., Bagdy, G., Moncada, M. L., & D’Agata, R. (1993) · Journal of Endocrinology · doi:10.1677/joe.0.1360381 · Cited by 60
Stress, Depression, and The Role of Cytokines
Leonard, B. E., & Song, C. (1999) · Advances in experimental medicine and biology · doi:10.1007/978-0-585-37970-8_14 · Cited by 59
Self-citation
Serotonergic‘vulnerability’ in affective disorder: a study of the tryptophan depletion test and relationships between peripheral and central serotonin indexes in citalopram‐responders
Åberg‐Wistedt, A., Hasselmark, L., Stain‐Malmgren, R., Apéria, B., Kjellman, B., & Mathé, A. A. (1998) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1998.tb10017.x · Cited by 56
Biochemical and medical aspects of tryptophan metabolism.
Hayaishi, O., Ishimura, Y., & Kido, R. (1980) · Cited by 53
Learned helplessness increases 5-hydroxytryptamine1B receptor mRNA levels in the rat dorsal raphe nucleus
Neumaier, J. F., Petty, F., Kramer, G. L., Szot, P., & Hamblin, M. W. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00114-x · Cited by 51
Concentration and microheterogeneity glycophorms of alpha-1-acid glycoprotein in major depressive disorder
Sluzewska, A. (1996) · Journal of Affective Disorders · doi:10.1016/0165-0327(96)00026-2 · Cited by 51
Long-lasting effects of an acute stress on the neurochemistry and function of 5-hydroxytryptaminergic neurones in the mouse brain
Davis, S., Stanford, S. C., & Heal, D. J. (1995) · Psychopharmacology · doi:10.1007/bf02245954 · Cited by 41
5-Hydroxytryptamine receptor function in humans is reduced by acute administration of hydrocortisone
Porter, R. J., McAllister-Williams, H., Lunn, B. S., & Young, A. H. (1998) · Psychopharmacology · doi:10.1007/s002130050711 · Cited by 32
Brain cytokines and the psychopathology of depression
Leonard, B. E. (2001) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8344-3_8 · Cited by 15
Self-citation
The Pharmacological Profile of (R)-3,4-Dihydro-N-isopropyl-3-(N-isopropyl-N-propylamino)-2H-1-benzopyran-5-carboxamide, a Selective 5-Hydroxytryptamine1A Receptor Agonist
Rényi, L., Evenden, J. L., Fowler, C. J., Jerning, E., Kelder, D., Lake‐Bakaar, D. M., Larsson, L.-G., Mohell, N., Sällemark, M., & Ross, S. B. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29206-5 · Cited by 11
Does selectivity matter?
Deakin, J. F. W. (1996) · International Clinical Psychopharmacology · doi:10.1097/00004850-199603001-00003 · Cited by 9
Untitled work
Laffel (1999) · doi:10.1002/(sici)1520-7560(199911/12)15:6

Research works printed but not linked: 3

10.1001%2Farchinte.153.18.2093 · DOI · Paper page
10.1176%2Fappi.ajgp.10.1.62 · DOI
10.1001%2Fjama.267.9.1244 · DOI · Paper page

Sorted by citations

The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner
Clarke, G., Grenham, S., Scully, P., Fitzgerald, P., Moloney, R. D., Shanahan, F., Dinan, T. G., & Cryan, J. F. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.77 · Cited by 1,893
Stress & the gut-brain axis: Regulation by the microbiome
Foster, J. A., Rinaman, L., & Cryan, J. F. (2017) · Neurobiology of Stress · doi:10.1016/j.ynstr.2017.03.001 · Cited by 1,150
Biological and psychological markers of stress in humans: Focus on the Trier Social Stress Test
Allen, A. P., Kennedy, P. J., Cryan, J. F., Dinan, T. G., & Clarke, G. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.11.005 · Cited by 734
Proinflammatory cytokines in the prefrontal cortex of teenage suicide victims
Pandey, G. N., Rizavi, H. S., Ren, X., Fareed, J., Hoppensteadt, D. A., Roberts, R. C., Conley, R. R., & Dwivedi, Y. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.08.006 · Cited by 378
Effects of environmental change on wildlife health
Acevedo‐Whitehouse, K. A., & Duffus, A. L. J. (2009) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2009.0128 · Cited by 388

See all 169

Authors: Leonard, B. E.
Affiliations: Ollscoil na Gaillimhe – University of Galway (IE)
Corresponding author: Leonard, Brian E.
Venue: Neuroimmunomodulation
Publisher: S. Karger AG
Published: 2006
Volume: 13
Issue: 5-6
Pages: 268-276
ISSN: 1021-7401 (ISSN-L)
1423-0216
DOI: 10.1159/000104854
OpenAlex: W2025883568
Cited by: 169
References: 69
Citations by year: 2026: 7 · 2025: 6 · 2024: 7 · 2023: 7 · 2022: 8 · 2021: 8 · 2020: 3 · 2019: 10 · 2018: 5 · 2017: 8 · 2016: 12 · 2015: 12 · 2014: 8 · 2013: 10 · 2012: 13
FWCI: 1.12
Type: journal article
Language: en
Open access: closed
Licence: www.karger.com/Services/SiteLicenses (vor)
www.karger.com/Services/SiteLicenses (tdm)
Locations: NeuroImmunoModulation (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
Keywords: chronic stress, hypothalamic-pituitary-adrenal axis, immune system, serotonergic system, inflammatory cytokines, glucocorticoids, depression, anxiety, hippocampus, prefrontal cortex, amygdala, neurodegeneration, dementia
MeSH terms: Animals, Anxiety, Brain, Chronic Disease, Depression, Glucocorticoids, Humans, Hypothalamo-Hypophyseal System, Nerve Degeneration, Pituitary-Adrenal System, Serotonin, Stress, Psychological, Cytokines

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

HPA and Immune Axes in Stress: Involvement of the Serotonergic System

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks